LRRK2 and Parkinson disease: Midbrain-like organoids generated from PD patients harboring the LRRK2-G2019S mutation revealed the increased expression of FOXA2, a transcription factor necessary for production of dopaminergic neurons, thus indicate a neurodevelopmental defect in midbrain dopaminergic neurons [36].